newsfilter
← Latest News
GlobeNewswire·

MaxCyte Celebrates 25 Years of Innovation Driving Cell Engineering-Based Therapeutics

ROCKVILLE, Md., Nov. 13, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT)), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and